4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,165.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 1,820.00
  • 52 Week Low: 930.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 2,156
  • Market Cap: £180.53m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-24 Interim 0.33 (6.14) (45.00)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.20 (0.53) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.46 (0.72) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 0.34 (3.64) (26.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.27 (5.93) (0.42)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.51 (8.35) (0.62)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

4basebio Market Data

Currency UK Pounds
Share Price 1,165.00p
Change Today 35.00p
% Change 3.10 %
52 Week High 1,820.00
52 Week Low 930.00
Volume 2,156
Shares Issued 15.50m
Market Cap £180.53m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.09% below the market average23.09% below the market average23.09% below the market average23.09% below the market average23.09% below the market average
29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average
Price Trend
55.36% above the market average55.36% above the market average55.36% above the market average55.36% above the market average55.36% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Income Not Available
Growth
37.90% above the market average37.90% above the market average37.90% above the market average37.90% above the market average37.90% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

4basebio Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:02 455 @ 1,150.00p
13:44 500 @ 1,130.00p
10:53 500 @ 1,150.00p
09:41 700 @ 1,150.00p
08:30 1 @ 1,150.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page